(c) 2024 PillSync.com

Amoxi-Tabs (amoxicillin 200 mg) Dailymed


Generic: amoxicillin


IMPRINT: BMP 208     SHAPE: round
    COLOR: purple

All Imprints

amoxi-tabs 150 mg oral tablet - bmp 208 round purple

amoxi-tabs 150 mg oral tablet - bmp 196 round green

amoxi-tabs tablet - bmp 213 round white

Go PRO for all pill images


Veterinary Tablets

For use in dogs and cats

Caution


Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description


Amoxi-Tabs (amoxicillin) is a semisynthetic antibiotic with a broad spectrum of activity. It provides bactericidal activity against a wide range of common gram-positive and gram-negative pathogens. Chemically, it is D(-)-α-amino-p-hydroxybenzyl penicillin trihydrate.

Clinical Pharmacology


Amoxi-Tabs is stable in the presence of gastric acid and may be given without regard to meals. It is rapidly absorbed after oral administration. It diffuses readily into most body tissues and fluids with the exception of brain and spinal fluid, except when meninges are inflamed. Most of the amoxicillin is excreted unchanged in the urine.

Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms. It acts through the inhibition of biosynthesis of cell wall mucopeptide. In vitro and/or in vivo studies have demonstrated the susceptibility of most strains of the following gram-positive and gram-negative bacteria: α- and β-haemolytic streptococci, nonpenicillinase-producing staphylococci, Streptococcus faecalis, Escherichia coli, and Proteus mirabilis. Because it does not resist destruction by penicillinase, it is not effective against penicillinase-producing bacteria, particularly resistant staphylococci. All strains of Pseudomonas and most strains of Klebsiella and Enterobacter are resistant.

Indications And Usage


Dogs


Amoxi-Tabs are indicated in the treatment of susceptible strains of the organisms causing the following infections:

Respiratory tract infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

Genitourinary tract infections (cystitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

Gastrointestinal tract infections (bacterial gastroenteritis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

Bacterial dermatitis due to Staphylococcus aureus, Streptococcus spp., and Proteus mirabilis.

Soft tissue infections (abscesses, lacerations, and wounds) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

Cats


Amoxi-Tabs are indicated in the treatment of susceptible strains of the organisms causing the following infections:

Upper respiratory tract infections due to Staphylococcus aureus, Streptococcus spp., and E. coli.

Genitourinary tract infections (cystitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

Gastrointestinal tract infections due to E. coli.

Skin and soft tissue infections (abscesses, lacerations, and wounds) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Pasteurella multocida.

As with all antibiotics, appropriate in vitro culturing and susceptibility testing of samples taken before treatment should be conducted.

Contraindications


The use of this drug is contraindicated in animals with a history of an allergic reaction to penicillin.

Warning


For use in dogs and cats only.

Adverse Reactions


Amoxicillin is a semisynthetic penicillin and has the potential for producing allergic reactions. If an allergic reaction occurs, administer epinephrine and/or steroids.

Dosage And Administration


Dogs


The recommended dosage is 5 mg/lb of body weight twice a day.

Cats


The recommended dosage is 50 mg (5–10 mg/lb) once a day.


Dosage should be continued for 5–7 days or 48 hours after all symptoms have subsided. If no improvement is seen in 5 days, review diagnosis and change therapy.

Storage And Handling Section


Do Not Store at Temperatures Above 25°C (77°F)

How Supplied


Amoxi-Tabs are supplied in 5 strengths: 50 mg, 100 mg, 150 mg, and 200 mg in bottles of 500 tablets; 400 mg in bottles of 250 tablets.


NADA #55-078 & #55-081, Approved by FDA

MADE IN INDIA

Distributed by: Pfizer Animal Health Div. of Pfizer Inc NY, NY 10017

P150135975-8004-06IN.00Jan 2008

Principal Display Panel - 150 Mg Tablet Bottle Label


amoxiâ–tabs ® (amoxicillin) Veterinary Tablets

For use in dogs only

Each film-coated tablet containsamoxicillin trihydrate equivalentto 150 mg of amoxicillin.

Caution: Federal law restricts thisdrug to use by or on the orderof a licensed veterinarian.

150 mg

500 tablets

NADA #55-078, Approved by FDA

Pfizer

Principal Display Panel - 200 Mg Tablet Bottle Label


amoxiâ–tabs ® (amoxicillin) Veterinary Tablets

For use in dogs only

Each film-coated tablet containsamoxicillin trihydrate equivalentto 200 mg of amoxicillin.

Caution: Federal law restricts thisdrug to use by or on the orderof a licensed veterinarian.

200 mg

500 tablets

NADA #55-078, Approved by FDA

Pfizer

Principal Display Panel - 400 Mg Tablet Bottle Label


amoxiâ–tabs ® (amoxicillin) Veterinary Tablets

For use in dogs only

Each film-coated tablet containsamoxicillin trihydrate equivalentto 400 mg of amoxicillin.

Caution: Federal law restricts thisdrug to use by or on the orderof a licensed veterinarian.

400 mg

250 tablets

NADA #55-078, Approved by FDA

Pfizer

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site